These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26535469)

  • 21. Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects.
    Ai Y; Markesbery W; Zhang Z; Grondin R; Elseberry D; Gerhardt GA; Gash DM
    J Comp Neurol; 2003 Jun; 461(2):250-61. PubMed ID: 12724841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression patterns for GDNF and its receptors in the human putamen affected by Parkinson's disease: a real-time PCR study.
    Bäckman CM; Shan L; Zhang YJ; Hoffer BJ; Leonard S; Troncoso JC; Vonsatel P; Tomac AC
    Mol Cell Endocrinol; 2006 Jun; 252(1-2):160-6. PubMed ID: 16644101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease.
    Whone A; Luz M; Boca M; Woolley M; Mooney L; Dharia S; Broadfoot J; Cronin D; Schroers C; Barua NU; Longpre L; Barclay CL; Boiko C; Johnson GA; Fibiger HC; Harrison R; Lewis O; Pritchard G; Howell M; Irving C; Johnson D; Kinch S; Marshall C; Lawrence AD; Blinder S; Sossi V; Stoessl AJ; Skinner P; Mohr E; Gill SS
    Brain; 2019 Mar; 142(3):512-525. PubMed ID: 30808022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracerebral administration of ultrasound-induced dissolution of lipid-coated GDNF microbubbles provides neuroprotection in a rat model of Parkinson's disease.
    Wang X; Cui G; Yang X; Zhang Z; Shi H; Zu J; Hua F; Shen X
    Brain Res Bull; 2014 Apr; 103():60-5. PubMed ID: 24583079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glial cell line-derived neurotrophic factor-levodopa interactions and reduction of side effects in parkinsonian monkeys.
    Miyoshi Y; Zhang Z; Ovadia A; Lapchak PA; Collins F; Hilt D; Lebel C; Kryscio R; Gash DM
    Ann Neurol; 1997 Aug; 42(2):208-14. PubMed ID: 9266731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased brain bio-distribution and chemical stability and decreased immunogenicity of an engineered variant of GDNF.
    Smith RC; O'Bryan LM; Mitchell PJ; Leung D; Ghanem M; Wilson JM; Hanson JC; Sossick S; Cooper J; Huang L; Merchant KM; Lu J; O'Neill MJ
    Exp Neurol; 2015 May; 267():165-76. PubMed ID: 25771799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and safety in rhesus monkeys of a monoclonal antibody-GDNF fusion protein for targeted blood-brain barrier delivery.
    Pardridge WM; Boado RJ
    Pharm Res; 2009 Oct; 26(10):2227-36. PubMed ID: 19609743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glial-derived neurotrophic factor rescues calbindin-D28k-immunoreactive neurons in alcohol-treated cerebellar explant cultures.
    McAlhany RE; West JR; Miranda RC
    J Neurobiol; 1997 Nov; 33(6):835-47. PubMed ID: 9369155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic intraventricular infusion of glial cell line-derived neurotrophic factor (GDNF) rescues some cerebellar Purkinje cells from heredodegeneration.
    Tolbert DL; Bradley MW; Tolod EG; Torres-Aleman I; Clark BR
    Exp Neurol; 2001 Aug; 170(2):375-9. PubMed ID: 11476604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal administration of glial-derived neurotrophic factor (GDNF) rapidly and significantly increases whole-brain GDNF level in rats.
    Bender TS; Migliore MM; Campbell RB; John Gatley S; Waszczak BL
    Neuroscience; 2015 Sep; 303():569-76. PubMed ID: 26166725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?
    Lindvall O; Wahlberg LU
    Exp Neurol; 2008 Jan; 209(1):82-8. PubMed ID: 17963752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
    Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
    Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety Assessment of AAV2-hGDNF Administered Via Intracerebral Injection in Rats for Treatment of Parkinson's Disease.
    Terse PS; Kells AP; Noker P; Wright JF; Bankiewicz KS
    Int J Toxicol; 2021; 40(1):4-14. PubMed ID: 33131343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Point source concentration of GDNF may explain failure of phase II clinical trial.
    Salvatore MF; Ai Y; Fischer B; Zhang AM; Grondin RC; Zhang Z; Gerhardt GA; Gash DM
    Exp Neurol; 2006 Dec; 202(2):497-505. PubMed ID: 16962582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective GDNF brain delivery using microspheres--a promising strategy for Parkinson's disease.
    Garbayo E; Montero-Menei CN; Ansorena E; Lanciego JL; Aymerich MS; Blanco-Prieto MJ
    J Control Release; 2009 Apr; 135(2):119-26. PubMed ID: 19154763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease.
    Yasuhara T; Shingo T; Muraoka K; Kobayashi K; Takeuchi A; Yano A; Wenji Y; Kameda M; Matsui T; Miyoshi Y; Date I
    J Neurosurg; 2005 Jan; 102(1):80-9. PubMed ID: 15658100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.
    Decressac M; Ulusoy A; Mattsson B; Georgievska B; Romero-Ramos M; Kirik D; Björklund A
    Brain; 2011 Aug; 134(Pt 8):2302-11. PubMed ID: 21712347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease.
    Gill SS; Patel NK; Hotton GR; O'Sullivan K; McCarter R; Bunnage M; Brooks DJ; Svendsen CN; Heywood P
    Nat Med; 2003 May; 9(5):589-95. PubMed ID: 12669033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed administration of glial cell line-derived neurotrophic factor (GDNF) protects retinal ganglion cells in a pig model of acute retinal ischemia.
    Kyhn MV; Klassen H; Johansson UE; Warfvinge K; Lavik E; Kiilgaard JF; Prause JU; Scherfig E; Young M; la Cour M
    Exp Eye Res; 2009 Dec; 89(6):1012-20. PubMed ID: 19735654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitigation of cerebellar neuropathy in globoid cell leukodystrophy mice by AAV-mediated gene therapy.
    Lin DS; Hsiao CD; Lee AY; Ho CS; Liu HL; Wang TJ; Jian YR; Hsu JC; Huang ZD; Lee TH; Chiang MF
    Gene; 2015 Oct; 571(1):81-90. PubMed ID: 26115766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.